Gilead, LEO Pharma accomplice to develop applications for inflammatory ailments By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) mentioned on Saturday that it entered right into a partnership with Denmark's LEO Pharma to...
inflammatory
(Reuters) - Gilead Sciences (NASDAQ:) mentioned on Saturday that it entered right into a partnership with Denmark's LEO Pharma to...
